Table 3 Post-transplant complications and kidney transplant outcomes in the studied population
RDsKT n = 350 | nRDsKT n = 322 | P | |
|---|---|---|---|
Glomerulonephritis, N. (%) | 51 (14.6) | 31 (9.6) | 0.050 |
Recurrent, N. | 30 | 14 | |
De novo, N. | 11 | 10 | |
Undetermined, N. | 10 | 7 | |
Rejection (main histologic diagnosis)a, N. (%) | 66 (18.9) | 62 (19.3) | 0.900 |
AMR, N. | 47 | 39 | |
TCMR, N. | 19 | 23 | |
Infection (≥ 1 episode), N. (%) | 223 (63.7) | 234 (72.7) | 0.013 |
UTI, No. (%) | 130 (37.1) | 133 (41.3) | 0.269 |
Recurrent UTI, N. (%) | 47 (13.4) | 39 (12.1) | 0.610 |
Urosepsis, N. (%) | 27 (7.7) | 36 (11.1) | 0.124 |
Viral infections, N. (%) | 96 (27.4) | 114 (35.4) | 0.026 |
Tumors (≥ 1 episode), N. (%) | 52 (14.9) | 58 (18.0) | 0.270 |
Skin tumors, N. (%) | 28 (8.0) | 27 (8.4) | 0.856 |
Solid tumors, N. (%) | 24 (6.8) | 31 (9.6) | 0.191 |
Hematolymphoid tumors, N. (%) | 1 (0.3) | 4 (1.2) | 0.149 |
Post-transplant diabetes, N. (%) | 54 (15.4) | 54 (16.8) | 0.640 |
Post-transplant dysmetabolism, N. (%) | 102 (29.1) | 82 (25.5) | 0.290 |
Hematologic complications, N. (%) | 65 (18.6) | 60 (18.6) | 0.980 |
Urologic complications, N. (%) | 54 (15.4) | 50 (15.5) | 0.970 |
Vascular complications, N. (%) | 30 (8.6) | 40 (12.4) | 0.100 |
Transplant failure, N. (%) | 58 (16.6) | 57 (17.7) | 0.700 |
Chronic AMR, N. | 7 | 14 | |
Acute rejection, N. | 5 | 6 | |
Glomerulonephritis (recurrent), N. | 13 | 6 | |
Glomerulonephritis (de novo), N. | 2 | 1 | |
Interstitial fibrosis/tubular atrophy, N. | 4 | 9 | |
Deceases with functioning kidney transplant, N. (%) | 23 (6.6) | 28 (8.7) | 0.300 |
Cardiovascular, N. | 8 | 5 | |
Infection/sepsis, N. | 6 | 14 | |
Cancer, N. | 6 | 7 | |
Other, N. | 3 | 2 |